AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,752,000 | +48.1% | 213,942 | 0.0% | 0.07% | +39.2% |
Q4 2018 | $1,183,000 | -49.7% | 213,942 | -19.8% | 0.05% | -40.0% |
Q3 2018 | $2,354,000 | -11.5% | 266,612 | 0.0% | 0.08% | -15.8% |
Q2 2018 | $2,661,000 | +110.2% | 266,612 | +100.7% | 0.10% | +106.1% |
Q1 2018 | $1,266,000 | – | 132,849 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
Ergoteles LLC | 849,000 | $300,000 | 0.01% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |